日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pan-cancer multi-omic ERBB2-HER2 characterization using next-generation sequencing and quantitative proteomics

利用新一代测序和定量蛋白质组学进行泛癌多组学ERBB2-HER2表征

Hunt, Allison L; Randall, Jamie; Ogata, Jonathan D; Johnston, Laura; Swain, Whitney; Melvin, Savannah; Sharma, Meenakshi; Calvert, Valerie; Maxwell, G Larry; Bateman, Nicholas W; Petricoin, Emanuel F; Conrads, Thomas P; Cannon, Timothy L

Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer.

定量 HER2 组织和血浆分析可预测曲妥珠单抗 deruxtecan 对乳腺癌的活性。

Tarantino Paolo, Kim Se-Eun, Hughes Melissa E, Kusmick Ross J, Smith Kalie, Brasó-Maristany Fara, Nyein Chan Nay Nwe, Paré Brunet Laia, Alder Laura, Garcia-Cortes Diana, Gomez Tejeda Zanudo Jorge, Pereslete Alyssa M, Noteware Laura, Moore Heather, Van Swearingen Amanda E D, Li Tianyu, Gupta Hersh, D'Amico Olivia, Martini Alba, Morganti Stefania, Spindel Jennifer, Cook Charmaine, McLaughlin Christine, Dvir Kathrin, Garrido-Castro Ana C, Sammons Sarah, Files Janet, Sendrick Kerry, Buck Simone, Dillon Deborah, Jeselsohn Rinath, Li Yvonne Y, Cherniack Andrew D, LoRusso Patricia, Lustberg Maryam, Vega-León Rosario, Pardo Francisco, Davis Justin, Mueller Claudius, Corgiat Brian, Curigliano Giuseppe, Anders Carey K, Petricoin Emanuel F, Rimm David L, Prat Aleix, Tayob Nabihah, Lin Nancy U, Tolaney Sara M

Laser capture microdissection

激光捕获显微切割

Liotta, Lance A; Conrads, Thomas P; Howard, Marissa A; Araujo, Robyn P; Petricoin, Emanuel F

Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer

MTA 协同 PRMT5 抑制剂 BMS-986504 与 KRAS 抑制剂联合使用是治疗 MTAP 缺失 KRAS 突变型胰腺癌的有效策略

Drizyte-Miller, Kristina; Engstrom, Lars D; Klomp, Jeffrey A; Stalnecker, Clint A; Stamey, Addison G; Taylor, Khalilah E; Roach, Mallory K; Robb, Ryan; Waters, Laura M; Calinisan, Andrew; Degan, Seamus; Chang, Wen-Hsuan; Helu, Xousaen M; Nguyen, David; Baldelli, Elisa; Pierobon, Mariaelena; Petricoin, Emanuel F; Briere, David M; Hallin, Jill; Christensen, James G; Bryant, Kirsten L; Cox, Adrienne D; Olson, Peter; Der, Channing J

Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer.

同时抑制 RAS-MAPK 通路和 PIKfyve 是胰腺癌的一种治疗策略

DeLiberty Jonathan M, Roach Mallory K, Stalnecker Clint A, Robb Ryan, Schechter Elyse G, Pieper Noah L, Taylor Khalilah E, Pita Lily M, Yang Runying, Bang Scott, Drizyte-Miller Kristina, Ackermann Sarah E, Nicewarner Peña Sheila R, Baldelli Elisa, Min Sophia M, Drewry David H, Petricoin Emanuel F 3rd, Morris John P 4th, Der Channing J, Cox Adrienne D, Bryant Kirsten L

Real-time functional proteomics enhances therapeutic targeting in precision oncology molecular tumor boards

实时功能蛋白质组学增强了精准肿瘤分子肿瘤委员会的治疗靶向性。

Hunt, Allison L; Randall, Jamie; Mansukhani, Mahesh M; Nyberg, Kara; Nutcharoen, Aratara; Davis, Justin; Corgiat, Brian; Mueller, Claudius; Melvin, Savannah; Sharma, Meenakshi; Johnston, Laura; Swain, Whitney; Abulez, Tamara; Bateman, Nicholas W; Maxwell, G Larry; Deeken, John; Benyounes, Amin; Petricoin, Emanuel F; Cannon, Timothy L; Conrads, Thomas P

Proteogenomic characterization of invasive breast tumors in young women

年轻女性浸润性乳腺肿瘤的蛋白质基因组学特征分析

Raj-Kumar, Praveen-Kumar; Liu, Jianfang; Soltis, Anthony R; Bateman, Nicholas W; Chen, Qingrong; Sturtz, Lori A; Deyarmin, Brenda; Pierobon, Mariaelena; Abulez, Tamara A; Praveen-Kumar, Anupama; Zhang, Xijun; Nguyen, Trinh; Yan, Chunhua; Hu, Ying; Guion, Kate; Hooke, Jeffrey A; Kovatich, Albert J; Fantacone-Campbell, Leigh; Mostoller, Brad; Kvecher, Leonid; Somiari, Stella; Steeg, Patricia S; Rajagopal, Padma Sheila; Darcy, Kathleen M; Lee, Jerry S H; Dalgard, Clifton L; Conrads, Thomas P; Petricoin, Emanuel F; Meerzaman, Daoud; Wilkerson, Matthew D; Lin, Xiaoying; Shriver, Craig D; Lipkowitz, Stanley; Hu, Hai

Editorial: Clinical implementation of precision oncology data to direct individualized and immunotherapy-based treatment strategies

社论:精准肿瘤学数据的临床应用,指导个体化和基于免疫疗法的治疗策略

Young, Nicholas A; Prosperi, Jenifer R; Freud, Aharon G; Yee, Nelson S; Petricoin, Emanuel F

Evaluating the Effect of KRAS Variants on Survival Outcomes and Therapy Response in Pancreatic Cancer

评估KRAS变异对胰腺癌生存结局和治疗反应的影响

Ebia, Matthew I; Blais, Edik M; Cui, Yujie; Petricoin, Emanuel F 3rd; Pishvaian, Michael; Gaddam, Srinivas; Gong, Jun; Osipov, Arsen; Hendifar, Andrew E

T-type calcium channels regulate medulloblastoma and can be targeted for therapy

T型钙通道调控髓母细胞瘤,可作为治疗靶点。

Dube, Collin J; Lai, Michelle; Zhang, Ying; Saha, Shekhar; Yener, Ulas; Hanif, Farina; Hudson, Kadie; Gibert, Myron K Jr; Marcinkiewicz, Pawel; Sun, Yunan; Vegiraju, Tanvika; Xu, Esther; Sorot, Aditya; Gallagher, Rosa I; Wulfkuhle, Julia D; Vernon, Ashley; Dell'Olio, Lily; Anbu, Rajitha; Mulcahy, Elizabeth; Kefas, Benjamin; Guessous, Fadila; Petricoin, Emanuel F; Abounader, Roger